MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Bay City Capital
Finance & Acquisition: Bay City
*Portfolio Companies: Bay City
Brain Cells, Inc
Parents
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Depression, Anxiety Disorders, Schizophrenia, Etc
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
*Industry: San Diego, California
*Portfolio Companies: Bay City
*Portfolio Companies: NeuroVentures
Medimmune Ventures
Venture Capital: Series D
Children
BrainCells Inc. had acquired the compound sabcomeline from London-based Proximagen, and planned to study the drug as a treatment for depression.
BrainCells Raises $1M, Moving Ahead Without CEO Schoeneck or CSO Barlow (2011)
Development of breakthrough small molecule therapeutics for diseases of the central nervous system (CNS)
Founded 2009
Has raised at least $77 million in venture capital since it was founded (2011)
Investors include Bay City Capital, MedImmuneVentures, New Enterprise Associates, Oxford Bioscience Partners, Technology Partners, Pappas Ventures, NeuroVentures, Mitsubishi UFJ Capital, Mizuho, and Alexandria Real Estate Equities.
Neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous
San Diego, California